Cite
Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 Cases.
MLA
Suzuki, Eiichiro, et al. “Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 Cases.” Oncology, vol. 79, no. 1/2, Dec. 2010, pp. 39–45. EBSCOhost, https://doi.org/10.1159/000318020.
APA
Suzuki, E., Furuse, J., Ikeda, M., Okusaka, T., Nakachi, K., Mitsunaga, S., Ueno, H., Morizane, C., Kondo, S., Shimizu, S., Kojima, Y., & Hagihara, A. (2010). Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 Cases. Oncology, 79(1/2), 39–45. https://doi.org/10.1159/000318020
Chicago
Suzuki, Eiichiro, Junji Furuse, Masafumi Ikeda, Takuji Okusaka, Kohei Nakachi, Shuichi Mitsunaga, Hideki Ueno, et al. 2010. “Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 Cases.” Oncology 79 (1/2): 39–45. doi:10.1159/000318020.